menu
    • menu

    Company profile for AOP Health

    NEW Drugs in Dev: 2
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    As a privately owned company AOP Health is devoted to long-term commitment, high quality, and continuity. For a small number of very special diseases the company is the sole supplier of some key therapeutic agents throughout the world.When founding AOP Health in 1996 – as AOP Orphan – my aim was to make targeted treatment available to the maximum number of patients with rare diseases. I realized that these patients are fre...
    As a privately owned company AOP Health is devoted to long-term commitment, high quality, and continuity. For a small number of very special diseases the company is the sole supplier of some key therapeutic agents throughout the world.When founding AOP Health in 1996 – as AOP Orphan – my aim was to make targeted treatment available to the maximum number of patients with rare diseases. I realized that these patients are frequently left alone in their suffering. As an entrepreneur the complex environment of rare diseases was a great challenge, but also an opportunity to be successful in this niche

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AOP HealthAustria Flag
    Country
    Country
    Austria
    Address
    Address
    Leopold-Ungar-Platz 2 1190 Vienna, Austria
    Telephone
    Telephone
    +43 1 503 7244
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aop-health.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AOP Health, VRG Therapeutics Unite on Inflammation Target
    AOP Health, VRG Therapeutics Unite on Inflammation Target

    12 May 2026

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/aop-health-vrg-therapeutics-unite-to-advance-inflammation-and-immunology-target/

    CONTRACTPHARMA
    12 May 2026
    Share Share
    AOP Health US Launches First Rapiblyk Treatment in US
    AOP Health US Launches First Rapiblyk Treatment in US

    28 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7234198

    FIRSTWORD PHARMA
    28 Apr 2026
    Share Share
    Frankfurt Court Upholds Besremi Arbitral Award For AOP Health
    Frankfurt Court Upholds Besremi Arbitral Award For AOP Health

    24 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7206633

    FIRSTWORD PHARMA
    24 Apr 2026
    Share Share
    FDA Approves RAPIBLYK for Pediatric SVT Treatment
    FDA Approves RAPIBLYK for Pediatric SVT Treatment

    15 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260415402673/en/AOP-Health-US-LLC-RAPIBLYK-landiolol-Approved-by-FDA-for-Use-in-Pediatric-Patients-with-Supraventricular-Tachycardia

    BUSINESSWIRE
    15 Apr 2026
    Share Share
    AOP Health Adopts Veeva Industry Cloud For Life Sciences
    AOP Health Adopts Veeva Industry Cloud For Life Sciences

    10 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aop-health-standardizes-on-veeva-industry-cloud-for-life-sciences-across-all-business-areas-302708991.html

    PR NEWSWIRE
    10 Mar 2026
    Share Share
    AOP Health on Rare Diseases: Collaboration. Innovation.
    AOP Health on Rare Diseases: Collaboration. Innovation.

    23 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-23/aop-health-on-rare-diseases-information-collaboration-innovation

    PHARMIWEB
    23 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search